{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:04:19Z","timestamp":1791180259808,"version":"4.1.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.semarthrit.2013.04.004","type":"journal-article","created":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T03:30:37Z","timestamp":1372476637000},"page":"178-186","source":"Crossref","is-referenced-by-count":70,"title":["Malignant lymphoma in primary Sj\u00f6gren\u2019s syndrome: An update on the pathogenesis and treatment"],"prefix":"10.1016","volume":"43","author":[{"given":"John G.","family":"Routsias","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Goules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Charalampakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiria","family":"Tzima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristea","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Voulgarelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/08916930410001708715","article-title":"Sjogren\u2019s syndrome","volume":"37","author":"Soliotis","year":"2004","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.semarthrit.2013.04.004_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","article-title":"Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype","volume":"98","author":"Smedby","year":"2006","journal-title":"J Nat Cancer Inst"},{"issue":"20","key":"10.1016\/j.semarthrit.2013.04.004_bib3","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","article-title":"The risk of lymphoma development in autoimmune diseases: a meta-analysis","volume":"165","author":"Zintzaras","year":"2005","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11926-003-0011-y","article-title":"Lymphoproliferation in autoimmunity and Sjogren\u2019s syndrome","volume":"5","author":"Voulgarelis","year":"2003","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.semarthrit.2013.04.004_bib5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","article-title":"Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren\u2019s syndrome","volume":"46","author":"Ioannidis","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","article-title":"Clinical evolution, and morbidity and mortality of primary Sjogren\u2019s syndrome","volume":"29","author":"Skopouli","year":"2000","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.semarthrit.2013.04.004_bib7","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3324\/haematol.2009.005983","article-title":"Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas","volume":"94","author":"Bende","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1074-7613(04)00079-2","article-title":"Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF","volume":"20","author":"Lesley","year":"2004","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nri799","article-title":"Marginal-zone B cells","volume":"2","author":"Martin","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1074-7613(03)00111-0","article-title":"Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development","volume":"18","author":"Saito","year":"2003","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib11","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1084\/jem.182.2.559","article-title":"Analysis of mutations in immunoglobulin heavy chain variable region genes of microdissected marginal zone (MGZ) B cells suggests that the MGZ of human spleen is a reservoir of memory B cells","volume":"182","author":"Dunn-Walters","year":"1995","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib12","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.20052033","article-title":"A checkpoint for autoreactivity in human IgM+ memory B cell development","volume":"203","author":"Tsuiji","year":"2006","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2013.04.004_bib13","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1365-2362.2010.02342.x","article-title":"Autoimmune response and target autoantigens in Sjogren\u2019s syndrome","volume":"40","author":"Routsias","year":"2010","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.04.004_bib14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.berh.2007.09.001","article-title":"Update on Sj\u00f6gren\u2019s syndrome autoimmune epithelitis: from classification to increased neoplasias","volume":"21","author":"Tzioufas","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1191\/0961203306lu2290rr","article-title":"The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: lessons from Sjogren\u2019s syndrome (autoimmune epithelitis)","volume":"15","author":"Mitsias","year":"2006","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1365-2249.2002.01752.x","article-title":"CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjogren\u2019s syndrome patients indicating their intrinsic activation","volume":"127","author":"Dimitriou","year":"2002","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"10.1016\/j.semarthrit.2013.04.004_bib17","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1002\/art.21936","article-title":"Identification of transitional type II B cells in the salivary glands of patients with Sjogren\u2019s syndrome","volume":"54","author":"Daridon","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.semarthrit.2013.04.004_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren\u2019s syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2013.04.004_bib19","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.4049\/jimmunol.179.7.4929","article-title":"Activation-induced cytidine deaminase expression in follicular dendritic cell networks and interfollicular large B cells supports functionality of ectopic lymphoid neogenesis in autoimmune sialoadenitis and MALT lymphoma in Sjogren\u2019s syndrome","volume":"179","author":"Bombardieri","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/BOR.0b013e328277ef4c","article-title":"An important role for B-cell activation factor and B cells in the pathogenesis of Sjogren\u2019s syndrome","volume":"19","author":"Mackay","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.04.004_bib21","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.4049\/jimmunol.0803588","article-title":"Ectopic germinal centers are rare in Sjogren\u2019s syndrome salivary glands and do not exclude autoreactive B cells","volume":"182","author":"Le Pottier","year":"2009","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.semarthrit.2013.04.004_bib22","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nri1786","article-title":"Lymphoid neogenesis in chronic inflammatory diseases","volume":"6","author":"Aloisi","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.semarthrit.2013.04.004_bib23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.autrev.2010.05.004","article-title":"Immunological profile in primary Sjogren syndrome: clinical significance, prognosis and long-term evolution to other auto-immune disease","volume":"9","author":"Fauchais","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.04.004_bib24","first-page":"1283","article-title":"Differential expression of Ro\/SSA 60kDa and La\/SSB, but not Ro\/SSA 52kDa, mRNA and protein in minor salivary glands from patients with primary Sjogren\u2019s syndrome","volume":"34","author":"Barcellos","year":"2007","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib25","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/art.1780390510","article-title":"Aberrant expression pattern of the SS-B\/La antigen in the labial salivary glands of patients with Sjogren\u2019s syndrome","volume":"39","author":"de Wilde","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2013.04.004_bib26","doi-asserted-by":"crossref","first-page":"948364","DOI":"10.1155\/2010\/948364","article-title":"Interferon alpha in systemic lupus erythematosus","volume":"2010","author":"Niewold","year":"2010","journal-title":"J Biomed Biotechnol"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib27","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-2133.2008.08508.x","article-title":"Interferon-alpha and viral triggers promote functional maturation of human monocyte-derived dendritic cells","volume":"158","author":"Farkas","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-3083.2007.02049.x","article-title":"B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjogren\u2019s syndrome","volume":"67","author":"Lavie","year":"2008","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib29","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/art.22458","article-title":"Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjogren\u2019s syndrome","volume":"56","author":"Daridon","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2249.2009.04007.x","article-title":"BAFF: a local and systemic target in autoimmune diseases","volume":"158","author":"Moisini","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.semarthrit.2013.04.004_bib31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.autrev.2010.05.006","article-title":"B-cell tolerance breakdown in Sjogren\u2019s syndrome: focus on BAFF","volume":"9","author":"Varin","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.semarthrit.2013.04.004_bib32","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.192.10.1453","article-title":"BAFF mediates survival of peripheral immature B lymphocytes","volume":"192","author":"Batten","year":"2000","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.4049\/jimmunol.172.2.812","article-title":"TNF deficiency fails to protect BAFF transgenic mice against autoimmunity and reveals a predisposition to B cell lymphoma","volume":"172","author":"Batten","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.semarthrit.2013.04.004_bib34","first-page":"61","article-title":"Gastric MALT lymphoma and Helicobacter pylori","volume":"69","author":"Wotherspoon","year":"1996","journal-title":"Yale J Biol Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2013.04.004_bib35","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1182\/blood-2007-08-109611","article-title":"Borrelia infection and risk of non-Hodgkin lymphoma","volume":"111","author":"Schollkopf","year":"2008","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.semarthrit.2013.04.004_bib36","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1158\/1078-0432.CCR-08-0676","article-title":"Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods","volume":"14","author":"Ponzoni","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.semarthrit.2013.04.004_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","article-title":"Immunoproliferative small intestinal disease associated with Campylobacter jejuni","volume":"350","author":"Lecuit","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib38","first-page":"873","article-title":"Prevalence of HCV infection and second neoplasms in marginal zone lymphomas","volume":"96","author":"Luppi","year":"1997","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.semarthrit.2013.04.004_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/art.22476","article-title":"Characterization of B cell lymphoma in patients with Sjogren\u2019s syndrome and hepatitis C virus infection","volume":"57","author":"Ramos-Casals","year":"2007","journal-title":"Arthritis and rheumatism"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1182\/blood.V96.2.410","article-title":"The gastric marginal zone B-cell lymphoma of MALT type","volume":"96","author":"Zucca","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.semarthrit.2013.04.004_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03009740500537945","article-title":"Progress and regression within primary Sjogren\u2019s syndrome","volume":"35","author":"Manthorpe","year":"2006","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2013.04.004_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-2249.2010.04144.x","article-title":"Polymerase chain reaction (PCR) detection of B cell clonality in Sjogren\u2019s syndrome patients: a diagnostic tool of clonal expansion","volume":"161","author":"Guzman","year":"2011","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib43","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/03009740310003884","article-title":"Analysis of B-cell clonality in the hepatic tissue of patients with Sjogren\u2019s syndrome","volume":"32","author":"Tokuno","year":"2003","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2013.04.004_bib44","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V89.9.3335","article-title":"Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas","volume":"89","author":"Bahler","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.04.004_bib45","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood.V91.6.1864","article-title":"Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjogren\u2019s syndrome) begin as nonmalignant antigen-selected expansions","volume":"91","author":"Bahler","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib46","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/1529-0131(200004)43:4<908::AID-ANR24>3.0.CO;2-K","article-title":"Salivary gland lymphomas in patients with Sjogren\u2019s syndrome may frequently develop from rheumatoid factor B cells","volume":"43","author":"Martin","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1084\/jem.173.2.487","article-title":"Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells","volume":"173","author":"Roosnek","year":"1991","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib48","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2559.2007.02580.x","article-title":"Cytogenetic abnormalities in MALT lymphomas and their precursor lesions from different organs. A fluorescence in situ hybridization (FISH) study","volume":"50","author":"Joao","year":"2007","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.semarthrit.2013.04.004_bib49","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/path.2466","article-title":"A20 deletion is associated with copy number gain at the TNFA\/B\/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands","volume":"217","author":"Chanudet","year":"2009","journal-title":"J Pathol"},{"issue":"7","key":"10.1016\/j.semarthrit.2013.04.004_bib50","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood.V91.7.2433","article-title":"Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1\/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas","volume":"91","author":"Ivanovski","year":"1998","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib51","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2000-9613","article-title":"The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy","volume":"20","author":"Dammacco","year":"2000","journal-title":"Semin Liver Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2013.04.004_bib52","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1182\/blood.V96.10.3578","article-title":"Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia","volume":"96","author":"De","year":"2000","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.semarthrit.2013.04.004_bib53","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1182\/blood.V95.12.3878","article-title":"Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features","volume":"95","author":"Miklos","year":"2000","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.semarthrit.2013.04.004_bib54","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","author":"Kuppers","year":"1999","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2013.04.004_bib55","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/1529-0131(199907)42:7<1466::AID-ANR21>3.0.CO;2-L","article-title":"Lymphoma development in Sjogren\u2019s syndrome: novel p53 mutations","volume":"42","author":"Tapinos","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/1024533021000024058","article-title":"Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis","volume":"7","author":"Rossi","year":"2002","journal-title":"Hematology"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.04.004_bib57","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1053\/gast.1997.v112.pm9178679","article-title":"Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas","volume":"112","author":"Neumeister","year":"1997","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib58","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/art.1780390508","article-title":"Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjogren\u2019s syndrome","volume":"39","author":"Tzioufas","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2013.04.004_bib59","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nrrheum.2010.118","article-title":"Pathogenetic mechanisms in the initiation and perpetuation of Sjogren\u2019s syndrome","volume":"6","author":"Voulgarelis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib60","first-page":"199","article-title":"The spectrum of benign to malignant lymphoproliferation in Sjogren\u2019s syndrome","volume":"10","author":"Anderson","year":"1972","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.04.004_bib61","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","article-title":"Increased risk of lymphoma in sicca syndrome","volume":"89","author":"Kassan","year":"1978","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2013.04.004_bib62","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/rheumatology\/keh407","article-title":"Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren\u2019s syndrome","volume":"44","author":"Ramos-Casals","year":"2005","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.semarthrit.2013.04.004_bib63","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","article-title":"Lymphoma and other malignancies in primary Sjogren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors","volume":"65","author":"Theander","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib64","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0049-0172(96)80019-9","article-title":"Clinicopathological factors relating malignant lymphoma with Sjogren\u2019s syndrome","volume":"25","author":"Anaya","year":"1996","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2013.04.004_bib65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","article-title":"Predictors of lymphoma development in primary Sjogren\u2019s syndrome","volume":"28","author":"Sutcliffe","year":"1998","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/030097401316909486","article-title":"Rheumatic diseases and malignancy\u2014is there an association?","volume":"30","author":"Leandro","year":"2001","journal-title":"Scand J Rheumatol"},{"issue":"10","key":"10.1016\/j.semarthrit.2013.04.004_bib67","first-page":"761","article-title":"Malignant lymphoma in primary Sjogren\u2019s syndrome","volume":"3","author":"Voulgarelis","year":"2001","journal-title":"Israel Med Assoc J"},{"issue":"8","key":"10.1016\/j.semarthrit.2013.04.004_bib68","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/1529-0131(199908)42:8<1765::AID-ANR28>3.0.CO;2-V","article-title":"Malignant lymphoma in primary Sjogren\u2019s syndrome: a multicenter, retrospective, clinical study by the European concerted action on Sjogren\u2019s syndrome","volume":"42","author":"Voulgarelis","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2013.04.004_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MD.0b013e31824125e4","article-title":"Prognosis and outcome of non-Hodgkin lymphoma in primary Sjogren syndrome","volume":"91","author":"Voulgarelis","year":"2012","journal-title":"Medicine"},{"issue":"5","key":"10.1016\/j.semarthrit.2013.04.004_bib70","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1309\/HRHQFBFTR8B4LXT4","article-title":"Bone marrow involvement by marginal zone B-cell lymphomas of different types","volume":"129","author":"Inamdar","year":"2008","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib71","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.rdc.2008.08.006","article-title":"Mucosa-associated lymphoid tissue lymphoma in Sjogren\u2019s syndrome: risks, management, and prognosis","volume":"34","author":"Voulgarelis","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"issue":"1\u20132","key":"10.1016\/j.semarthrit.2013.04.004_bib72","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/10428199609045724","article-title":"Evaluation of the international index in the prognosis of high grade gastric malt lymphoma","volume":"24","author":"Castrillo","year":"1996","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.semarthrit.2013.04.004_bib73","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-011-1226-z","article-title":"Non-gastric marginal zone B cell lymphoma: clinicopathologic features and treatment results","author":"Gill","year":"2011","journal-title":"Ann Hematol"},{"issue":"10","key":"10.1016\/j.semarthrit.2013.04.004_bib74","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.3899\/jrheum.110077","article-title":"Treatment of mucosa-associated lymphoid tissue lymphoma in Sjogren\u2019s syndrome: a retrospective clinical study","volume":"38","author":"Pollard","year":"2011","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2013.04.004_bib75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.autrev.2010.05.007","article-title":"The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjogren\u2019s syndrome","volume":"9","author":"Saraux","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.semarthrit.2013.04.004_bib76","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sjogren\u2019s syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.semarthrit.2013.04.004_bib77","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1182\/blood-2002-11-3496","article-title":"Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type","volume":"102","author":"Conconi","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.semarthrit.2013.04.004_bib78","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1200\/JCO.1995.13.10.2524","article-title":"Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression","volume":"13","author":"Hammel","year":"1995","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.semarthrit.2013.04.004_bib79","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1200\/JCO.2002.05.117","article-title":"Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study","volume":"20","author":"Jager","year":"2002","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.semarthrit.2013.04.004_bib80","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/rheumatology\/keh248","article-title":"Combined therapy with rituximab plus cyclophosphamide\/doxorubicin\/vincristine\/prednisone (CHOP) for Sjogren\u2019s syndrome-associated B-cell aggressive non-Hodgkin\u2019s lymphomas","volume":"43","author":"Voulgarelis","year":"2004","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.semarthrit.2013.04.004_bib81","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/ard.2005.046193","article-title":"Long term remission of Sjogren\u2019s syndrome associated aggressive B cell non-Hodgkin\u2019s lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)","volume":"65","author":"Voulgarelis","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.semarthrit.2013.04.004_bib82","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1002\/art.10434","article-title":"2-Chloro-2\u2032-deoxyadenosine in the treatment of Sjogren\u2019s syndrome-associated B cell lymphoproliferation","volume":"46","author":"Voulgarelis","year":"2002","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017213000590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017213000590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T19:57:43Z","timestamp":1645905463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017213000590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0049017213000590"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2013.04.004","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}